Cargando…

ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1

BACKGROUND: Increasing evidence has indicated an important role for estrogen receptor beta 1 (ERβ1) in breast cancer. However, the role of ERβ1 in the metastasis of androgen receptor (AR)-positive triple-negative breast cancer (TNBC) and the underlying mechanisms are still unknown. METHODS: Stable E...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Wei, Tang, Lin, Xu, Yumei, Sun, Qian, Yang, Fang, Guan, Xiaoxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460479/
https://www.ncbi.nlm.nih.gov/pubmed/28583190
http://dx.doi.org/10.1186/s13046-017-0545-x
_version_ 1783242183933952000
author Song, Wei
Tang, Lin
Xu, Yumei
Sun, Qian
Yang, Fang
Guan, Xiaoxiang
author_facet Song, Wei
Tang, Lin
Xu, Yumei
Sun, Qian
Yang, Fang
Guan, Xiaoxiang
author_sort Song, Wei
collection PubMed
description BACKGROUND: Increasing evidence has indicated an important role for estrogen receptor beta 1 (ERβ1) in breast cancer. However, the role of ERβ1 in the metastasis of androgen receptor (AR)-positive triple-negative breast cancer (TNBC) and the underlying mechanisms are still unknown. METHODS: Stable ERβ1-expressing TNBC cell lines were generated for this study. We detected the abilities of cell migration and invasion by wound-healing and transwell assays and the expression of E-cadherin and N-cadherin by quantitative RT-PCR (qRT-PCR) and western blotting assays in TNBC cell lines. Chromatin immunoprecipitation (ChIP) analysis was performed to assess the effect of AR on ERβ1 promoter. Tumor metastasis was evaluated in vivo using a lung metastasis mouse model. Lastly, immunohistochemical expression of ERβ1 in TNBC tissues was analyzed and correlated with clinicopathological features. RESULTS: ERβ1 suppressed the invasion and migration abilities of AR-positive TNBC cells and induced the downregulation of ZEB1. ZEB1 overexpression abrogated the increase in E-cadherin expression and the decrease in N-cadherin expression modulated by ERβ1. A lung metastasis mouse model showed that the incidence of metastasis was lower in ERβ1-expressing TNBC cells. Further, AR activation increased the anti-metastatic effect of ERβ1 in AR-positive TNBC cells, which accelerated ERβ1 transcription by functioning as a transcription factor that bound to the promoter of ERβ1. No significant change was observed in AR expression induced by ERβ1. Immunohistochemistry (IHC) analysis of TNBC clinical samples showed that ERβ1 and AR were positive in 31.7% and 23.2% of samples, respectively. ERβ1 expression was negatively correlated with ZEB1 expression and lymph node metastasis, and positively correlated with the expression of AR and E-cadherin. CONCLUSION: Our findings suggested a potential role of ERβ1 in metastasis of AR-positive TNBC and provided novel insights into the mechanism of action of ERβ1 and the possible relationship between ERβ1 and AR.
format Online
Article
Text
id pubmed-5460479
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54604792017-06-07 ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1 Song, Wei Tang, Lin Xu, Yumei Sun, Qian Yang, Fang Guan, Xiaoxiang J Exp Clin Cancer Res Research BACKGROUND: Increasing evidence has indicated an important role for estrogen receptor beta 1 (ERβ1) in breast cancer. However, the role of ERβ1 in the metastasis of androgen receptor (AR)-positive triple-negative breast cancer (TNBC) and the underlying mechanisms are still unknown. METHODS: Stable ERβ1-expressing TNBC cell lines were generated for this study. We detected the abilities of cell migration and invasion by wound-healing and transwell assays and the expression of E-cadherin and N-cadherin by quantitative RT-PCR (qRT-PCR) and western blotting assays in TNBC cell lines. Chromatin immunoprecipitation (ChIP) analysis was performed to assess the effect of AR on ERβ1 promoter. Tumor metastasis was evaluated in vivo using a lung metastasis mouse model. Lastly, immunohistochemical expression of ERβ1 in TNBC tissues was analyzed and correlated with clinicopathological features. RESULTS: ERβ1 suppressed the invasion and migration abilities of AR-positive TNBC cells and induced the downregulation of ZEB1. ZEB1 overexpression abrogated the increase in E-cadherin expression and the decrease in N-cadherin expression modulated by ERβ1. A lung metastasis mouse model showed that the incidence of metastasis was lower in ERβ1-expressing TNBC cells. Further, AR activation increased the anti-metastatic effect of ERβ1 in AR-positive TNBC cells, which accelerated ERβ1 transcription by functioning as a transcription factor that bound to the promoter of ERβ1. No significant change was observed in AR expression induced by ERβ1. Immunohistochemistry (IHC) analysis of TNBC clinical samples showed that ERβ1 and AR were positive in 31.7% and 23.2% of samples, respectively. ERβ1 expression was negatively correlated with ZEB1 expression and lymph node metastasis, and positively correlated with the expression of AR and E-cadherin. CONCLUSION: Our findings suggested a potential role of ERβ1 in metastasis of AR-positive TNBC and provided novel insights into the mechanism of action of ERβ1 and the possible relationship between ERβ1 and AR. BioMed Central 2017-06-05 /pmc/articles/PMC5460479/ /pubmed/28583190 http://dx.doi.org/10.1186/s13046-017-0545-x Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Song, Wei
Tang, Lin
Xu, Yumei
Sun, Qian
Yang, Fang
Guan, Xiaoxiang
ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1
title ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1
title_full ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1
title_fullStr ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1
title_full_unstemmed ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1
title_short ERβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing ZEB1
title_sort erβ1 inhibits metastasis of androgen receptor-positive triple-negative breast cancer by suppressing zeb1
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460479/
https://www.ncbi.nlm.nih.gov/pubmed/28583190
http://dx.doi.org/10.1186/s13046-017-0545-x
work_keys_str_mv AT songwei erb1inhibitsmetastasisofandrogenreceptorpositivetriplenegativebreastcancerbysuppressingzeb1
AT tanglin erb1inhibitsmetastasisofandrogenreceptorpositivetriplenegativebreastcancerbysuppressingzeb1
AT xuyumei erb1inhibitsmetastasisofandrogenreceptorpositivetriplenegativebreastcancerbysuppressingzeb1
AT sunqian erb1inhibitsmetastasisofandrogenreceptorpositivetriplenegativebreastcancerbysuppressingzeb1
AT yangfang erb1inhibitsmetastasisofandrogenreceptorpositivetriplenegativebreastcancerbysuppressingzeb1
AT guanxiaoxiang erb1inhibitsmetastasisofandrogenreceptorpositivetriplenegativebreastcancerbysuppressingzeb1